Revolution Medicines/RVMD

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Revolution Medicines

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

Ticker

RVMD

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Redwood City, United States

Employees

411

RVMD Metrics

BasicAdvanced
$6.2B
Market cap
-
P/E ratio
-$3.71
EPS
1.46
Beta
-
Dividend rate
$6.2B
1.46
18.45
18.176
4.628
5.102
-1,740.55%
-22.11%
-36.17%
1,069.37
3.57
3.73
-10.66
-86.89%
22.83%
-52.11%
24.32%

What the Analysts think about RVMD

Analyst Ratings

Majority rating from 13 analysts.
Buy

RVMD Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
-100.00%
Net income
-$116M
-28.17%
Profit margin
0.00%
-100.00%

RVMD Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 6.18%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.92
-$0.99
-$1.14
-$0.70
-
Expected
-$0.82
-$1.01
-$0.88
-$0.75
-$0.75
Surprise
11.68%
-1.29%
29.24%
-6.18%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Revolution Medicines stock?

Revolution Medicines (RVMD) has a market cap of $6.2B as of July 04, 2024.

What is the P/E ratio for Revolution Medicines stock?

The price to earnings (P/E) ratio for Revolution Medicines (RVMD) stock is 0 as of July 04, 2024.

Does Revolution Medicines stock pay dividends?

No, Revolution Medicines (RVMD) stock does not pay dividends to its shareholders as of July 04, 2024.

When is the next Revolution Medicines dividend payment date?

Revolution Medicines (RVMD) stock does not pay dividends to its shareholders.

What is the beta indicator for Revolution Medicines?

Revolution Medicines (RVMD) has a beta rating of 1.46. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Revolution Medicines stock

Buy or sell Revolution Medicines stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing